You are here:

alteplase (Actilyse Cathflo 2mg)

Advice

following an abbreviated submission:

alteplase 2mg powder and solvent for solution for injection (Actilyse Cathflo®) is accepted for restricted use within NHS Scotland.

Indication under review: thrombolytic treatment of occluded central venous access devices including those used for haemodialysis.

SMC restriction: to use where alteplase is the product of choice for the treatment of occluded venous access devices.

This is a new formulation introduced for this extension to the alteplase marketing authorisation and the 2 ml vial is the only presentation licensed for this indication.

Drug Details

Drug Name: alteplase (Actilyse Cathflo 2mg)
SMC Drug ID: 717/11
Manufacturer: Boehringer Ingelheim Ltd
Indication: For thrombolytic treatment of occluded ventral venous access devices (CVAD).
BNF Category:
Sub Category: 2.10 Myocardial infarction and fibrinolysis
Submission Type: Abbreviated Submission
Status: Restricted
Date Advice Published: 8 August 2011

Back